Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies: A single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction

European Heart Journal

Volumn 23, Issue 19, 2002, Pages 1529-1537

  Ronner, E ^a   Van Domburg, R T ^a   Van Den Brand, M J B M ^a   De Feyter, P J ^a   Foley, D P ^a   Van Der Giessen, W J ^a   Serruys, P W ^a   Simoons, Maarten L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; Haemorrhage; Infarction; Plasminogen activators; Streptokinase; Thrombolysis

Indexed keywords

ABCIXIMAB; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AORTA BALLOON; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART TAMPONADE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; FEMALE; FIBRINOLYTIC AGENTS; HEART VENTRICLES; HEMORRHAGE; HEPARIN; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REOPERATION; REPERFUSION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE;

EID: 0036797224     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3169     Document Type: Article

References (44)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
2. Langer A, Krucoff MW, Klootwijk P et al., for the GUSTO-I ECG Monitoring Substudy Group. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: The GUSTO-I ST segment monitoring substudy. J Am Coll Cardiol 1998; 31: 783-9.
3. Davies CH, Ornerod OJM. Failed coronary thrombolysis. Lancet 1999; 351: 1191-6.
4. The CORAMI Study Group. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Cohort of rescue angioplasty in myocardial infarction. Am J Cardiol 1994; 74: 172-4.
5. Baim DS, Diver DJ, Knatterud GL, and the TIMI 2A Investigators. PTCA 'salvage' for thrombolytic failures: Implications from TIMI 2A. Circulation 1988; 78 (Suppl II): II-112.
6. White HD, Cross DB, Williams BF et al. 'Rescue' thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction. Am J Cardiol 1995; 75: 172-4.
7. Becker RC. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion. Clin Cardiol 1994; 17: 3-13.
8. Simoons ML, Arnout J, Van den Brand M, Nyssen K, Verstraete M. Retreatment with Alteplase for early signs of reoclusion after thrombolysis. The European Cooperative Study Group. Am J Cardiol 1993; 71: 524-8.
9. Miller JM, Smalling R, Ohman EM et al. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global use of strategies to open occluded coronary arteries. Am J Cardiol 1999; 84: 779-84.
10. Muhlestein JB, Karagounis LA, Treehan S et al. 'Rescue' utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. J Am Coll Cardiol 1997; 30: 1724-9.
11. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
12. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
13. The EPISTENT investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87-92.
14. The GUSTO V investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. Lancet 2001; 357: 1905-14.
15. Ronner E, Zijnen P, Altmann E et al. Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction. A phase II dose escalation, randomized, double-blind study. Eur Heart J 2000; 18: 1530-6.
16. Antman EM, Giugliano RP, Gibson MC et al., for the TIMI 14 investigators. Abciximab facilitates the rate and extent of thrombolysis. Results of the thrombolyis in myocardial infarction (TIMI) 14 trial. Circulation 1999; 99: 2720-32.
17. INTRO-AMI was presented at the 21st Congress of the European Society of Cardiology in Barcelona September 1999.
18. Jong P, Cohen EA, Batchelor W et al. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction. Am Heart J 2001; 141: 218-25.
19. Schröder R, Dissman R, Brüggemann T et al. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute AMI. J Am Coll Cardiol 1994; 24: 389-91.
20. Bär F, Vainer J, Stevenhagen J et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol 2000: 36: 51-8.
21. Hasdai D et al. Euro Heart Survey, Presented at the 23rd Congress of the European Society of Cardiology in Stockholm, 2001.
22. Stenestrand U, Wallentin L. Swedish National Database; RIKS-HIA Database. Data on file.
23. Simes RJ, Topol EJ, Holmes DR et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial perfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995; 91: 1905.
24. Ohman EM, Califf RM, Topol EJ et al. and the TAMI study group. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781-91.
25. Topol EJ, Califf RM, George BS et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987; 317: 581-8.
26. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ 1991; 302: 555-60.
27. Ellis SG, De Silva RE, Heyndrickx G et al., for the RESCUE investigators. Randomized comparison of rescue angioplasty with conservative management of patients with early failure thrombolysis for AMI. Circulation 1994; 90: 2280-4.
28. Ross AM, Lundergan CF, Rohrbeck SC et al. Rescue angioplasty after failed thrombolysis: Technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1998; 31: 1511-7.
29. Gibson CM, Cannon CP, Greene RM et al. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. Am J Cardiol 1997; 80: 16-21.
30. Tebbe U, Michels R, Adgey AAJ et al. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS equivalence trial. Comparison trial of saruplase and streptokinase (COMASS) investigators. J Am Coll Cardiol 1998; 31: 487-93.
31. Schroder R, Wegscheider K, Schroder K et al., for the INJECT Trial Group. Extent of early ST segment elevation resolution: A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial. J Am Coll Cardiol 1996; 26: 1657-67.
32. Betriu A, Califf RM, Bosch X et al. Recurrent ischemia after thrombolysis: Importance of associated clinical findings. Gusto-I investigators. J Am Coll Cardiol 1998; 31: 94-102.
33. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both -on coronaryartery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
34. Bär F, Vainer J, Stevenhagen J et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol 2000; 36: 51-8.
35. Ellis GE, Da Silva ER, Spaulding CM, Nobuyoshi M, Weiner B, Talley D. Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000; 139: 1046-53.
36. Grines CL, Browne KF, Marco J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
37. Bär F, Vainer J, Stevenhagen J et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction. J Am Coll Cardiol 2000; 36: 51-8.
38. HART-2, presented at the 49th Annual Scientific Sessions of the American College of Cardiology, Anaheim, March 2000.
39. SK-AMI, presented at the 50th Annual Scientific Sessions of the American College of Cardiology, Orlando, March 2001.
40. Kontny F, Dale J, Abildgaard U, Pedersen TR. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: The Fragmin in Acute Myocardial Infarction (FRAMI) Study. J Am Coll Cardiol 1997; 30: 962-9.
41. Simoons ML, Arnold AE. Tailored thrombolytic therapy. A perspective. Circulation 1993; 88: 2556-64.
42. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
43. Zijlstra F, de Boer MJ, Hoomtje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
44. Abbottsmith CW, Topol EJ, George BS et al. Fate of patients with acute AMI with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 1990; 16: 770-8.